This article, featuring insights from James Blakemore and Leigh Shelford, explores how ESCMID 2025 marked a shift from technology-led innovation to outcome-led diagnostics. Covering key themes including AMR, syndromic testing, sequencing, and AI, it highlights why usability, integration, and real-world impact are now critical to platform success.
This article, featuring insights from Tom Brittain, James Boonzaier and Jack Hornsby – the RAS leadership team at Cambridge Design Partnership – explores how a skunkworks approach, underpinned by capability, capacity and culture, enables surgical robotics companies to accelerate development, reduce risk, and bring new RAS technologies to market with speed and confidence.
This article, authored by Steve Augustyn, featuring insights from Krai Chatamra, VP of Clinical Development at Intrance Medical Systems, explores the necessity of advanced therapies that provide consistent symptom control to improve patient outcomes and enable a more independent lifestyle.
Fran Pencliffe of Cambridge Design Partnership explores the benefits of platform devices for parenteral delivery and outlines the challenges, risks and best practices when bringing a combination product to market in this way.
The pharma industry’s move towards larger volumes of subcutaneous (SC) therapeutics and home-based care is increasing the demand for self-administration devices. We recently partnered with KORU to explore innovations in infusion pump technology aimed at enhancing patient comfort and convenience
We recently partnered with Re-Vana Therapeutics, pioneers in sustained-release technologies for a range of eye diseases. In this article, Re-Vana's Patrick H. O'Ruane, along with Cambridge Design Partnership's Dariusz Zak and Fran Pencliffe, discuss how advancing sustained-release therapies can help ease the burden of acute treatments.
We recently collaborated with Lent Innovations to explore critical issues in pediatric epinephrine injectors. Our latest article features insights from Dr. Annie Lent and our Deputy Head of Drug Delivery, Steve Augustyn.
Sergio explores single-use endoscopes and our framework for designing a greener solution. Focusing on sustainability, balancing environmental benefits with clinical outcomes and commercial opportunities through creative, data-driven strategies.
Insights from Industry Experts on Training for Patient Technique, the Value of Connected Devices, and the Shift to Low GWP pMDIs.
We are honored to announce our involvement in a remarkable awareness campaign with Cure Usher, Havas Lynx, and Push Films: the world's first 'touchable memory' device.
Multidisciplinary teams with diverse industry experience can dramatically speed up your new product development, securing you first-mover advantage.
In a recent Q&A with Healthcare Packaging, CDP’s Clare Beddoes and Stephen Augustyn discuss the latest trends in on-body large volume injectors (LVIs) and what they expect to see in 2024.